Dr Reddys Betapharm gets 8 drug contracts in Germany

Dr Reddy’s Laboratories on Wednesday announced that Betapharm AG, its wholly-owned subsidiary, has been tentatively offered eight products in different regions of Germany covering the AOK-insured persons.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol

Home » News » Business

Dec 11, 2008, 09.12 AM | Source: Business Line

Dr Reddy's Betapharm gets 8 drug contracts in Germany

Dr Reddy’s Laboratories on Wednesday announced that Betapharm AG, its wholly-owned subsidiary, has been tentatively offered eight products in different regions of Germany covering the AOK-insured persons.

Like this story, share it with millions of investors on M3

Dr Reddys Betapharm gets 8 drug contracts in Germany

Dr Reddy’s Laboratories on Wednesday announced that Betapharm AG, its wholly-owned subsidiary, has been tentatively offered eight products in different regions of Germany covering the AOK-insured persons.

Post Your Comments

Share Cancel

Hyderabad, Dec. 10

Dr Reddy’s Laboratories on Wednesday announced that Betapharm AG, its wholly-owned subsidiary, has been tentatively offered eight products in different regions of Germany covering the AOK-insured persons.

In a press release, the Hyderabad-based, pharma major said that it has received complete information on the preliminary result of the tender by the Allgemeine Ortskrankenkassen (AOK) for discount agreements for 47 of the 48 products pertaining to Betapharm.

The tender procedure is yet to be concluded and is expected to face potential legal objections by several companies. On signing the final contracts with AOK, Betapharm will be the sole supplier for the AOK-insured persons for these eight products in the awarded regions.

Mr V.S. Vasudevan, President, European Operations, Dr. Reddy’s, said, “The preliminary results of the AOK tender establish Betapharm’s competitiveness in the tender segment of the market in Germany. For the eight products offered, we expect a significant increase in volume though at relatively lesser margins and for the balance portfolio, we expect the competitive intensity to continue.

“We believe that Betapharm is well positioned to leverage these strengths to continue to build a competitive business in all segments of the generics market in Germany”, said the Managing Director and Chief Operating Officer, Dr Reddy’s, Mr Satish Reddy.

Taken from Business Line

thehindubusinessline.in

Buy, Hold, Sell ? Hear it first on M3
Dr Reddys Betapharm gets 8 drug contracts in Germany
New Member
1 Follower

Price when posted: BSE: Rs3159.80 ( -0.63 % ), NSE: Rs. 3155.60 ( -0.78 % )

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login